Rapid Micro Biosystems (NASDAQ:RPID) Posts Earnings Results, Beats Expectations By $0.01 EPS

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) issued its quarterly earnings results on Friday. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.01, Zacks reports. Rapid Micro Biosystems had a negative net margin of 184.93% and a negative return on equity of 48.05%. The business had revenue of $7.21 million during the quarter, compared to the consensus estimate of $6.63 million. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.

Rapid Micro Biosystems Price Performance

NASDAQ:RPID opened at $3.08 on Friday. The stock has a market cap of $133.17 million, a PE ratio of -2.75 and a beta of 1.13. Rapid Micro Biosystems has a fifty-two week low of $0.58 and a fifty-two week high of $4.04. The stock's 50-day moving average is $2.38 and its two-hundred day moving average is $1.85.

Analyst Ratings Changes

Separately, KeyCorp began coverage on Rapid Micro Biosystems in a report on Wednesday, February 12th. They issued an "overweight" rating and a $8.00 target price for the company.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.